Journal
KIDNEY INTERNATIONAL SUPPLEMENTS
Volume 1, Issue 3, Pages 68-73Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/kisup.2011.16
Keywords
cell-based therapy; chronic kidney disease; glomerulonephritis; mesenchymal stem cell(s); progenitors; renal regeneration
Categories
Funding
- European Community [HEALTH-F5-2008-223007 STAR-TREK]
- German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB TRR57]
Ask authors/readers for more resources
Most studies using adult stem cells (ASCs) and progenitor cells as potential therapeutics for kidney disorders have been conducted in models of acute kidney injury, where the damage mainly affects the tubulointerstitium. The results are promising, whereas the underlying mechanisms are still being discussed controversially. Glomerular diseases have not received as much attention. Likely reasons include the often insidious onset, rendering the choice of optimal treatment timing difficult, and the fact that chronic diseases may require long-term therapy. In this mini review, we summarize current strategies in adult stem cell-based therapies for glomerular diseases. In addition, we focus on possible side effects of stem cell administration that have been reported recently, that is, profibrotic actions and maldifferentiation of mesenchymal stem cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available